Ivan J. Cohen
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 12
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 3
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Ronald G. Blasberg (6 shared papers)Luís Felipe Campesato (1 shared paper)David Redmond (1 shared paper)Levi Mark B Mangarin (1 shared paper)Stephane Pourpe (1 shared paper)Mathieu Gigoux (1 shared paper)Roberta Zappasodi (1 shared paper)Taha Merghoub (1 shared paper)
- Journals
- Molecular Therapy — Oncolytics (2 papers)Cancers (2 papers)Blood (1 paper)Science Immunology (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Ivan J. Cohen
21 papers receiving 1.3k citations
Ivan J. Cohen's Hit Papers
Peers
Comparison fields: 5 of 61
- Biological Psychiatry 28
- Oncology 378
- Cancer Research 143
- Immunology 148
- Genetics 17
Countries citing papers authored by Ivan J. Cohen
This map shows the geographic impact of Ivan J. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan J. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan J. Cohen more than expected).
Fields of papers citing papers by Ivan J. Cohen
This network shows the impact of papers produced by Ivan J. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan J. Cohen. The network helps show where Ivan J. Cohen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan J. Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine Hit paper breakdown → | 2020 | 412 |
| 2 | CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours Hit paper breakdown → | 2021 | 327 |
| 3 | 2018 | 103 | |
| 4 | 2016 | 88 | |
| 5 | 2020 | 83 | |
| 6 | 2017 | 45 | |
| 7 | 2024 | 39 | |
| 8 | 2024 | 35 | |
| 9 | 2025 | 34 | |
| 10 | 2020 | 30 | |
| 11 | 2023 | 28 | |
| 12 | 2023 | 26 | |
| 13 | 2023 | 25 | |
| 14 | 2022 | 17 | |
| 15 | 2022 | 15 | |
| 16 | 2026 | 7 | |
| 17 | 2022 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2026 | 4 | |
| 20 | 1978 | 1 |
About Ivan J. Cohen
Ivan J. Cohen is a scholar working on Oncology, Cancer Research, Cognitive Neuroscience, Biomedical Engineering and Molecular Biology, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hearing Loss and Rehabilitation (2 papers), Ubiquitin and proteasome pathways (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Biological Psychiatry (28 citations), Oncology (378 citations), Cancer Research (143 citations), Immunology (148 citations) and Genetics (17 citations). Ivan J. Cohen has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Ronald G. Blasberg, Luís Felipe Campesato, David Redmond, Levi Mark B Mangarin, Stephane Pourpe, Mathieu Gigoux, Roberta Zappasodi, Taha Merghoub, Dmitriy Zamarin and Jeremy H. Tchaicha. Their work appears in journals such as Molecular Therapy — Oncolytics, Cancers, Blood, Science Immunology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.